Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis
Abstract Tumour necrosis factor (TNF) signalling is mediated via two receptors, TNF-receptor 1 (TNFR1) and TNF-receptor 2 (TNFR2), which work antithetically to balance CNS immune responses involved in autoimmune diseases such as multiple sclerosis. To determine the therapeutic potential of selective...
Guardado en:
Autores principales: | Sarah K. Williams, Richard Fairless, Olaf Maier, Patricia C. Liermann, Kira Pichi, Roman Fischer, Ulrich L. M. Eisel, Roland Kontermann, Andreas Herrmann, Babette Weksler, Nacho Romero, Pierre-Olivier Couraud, Klaus Pfizenmaier, Ricarda Diem |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d5fda7e325a49d7ac87de90f8d6525b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Progranulin as a Potential Therapeutic Target in Immune-Mediated Diseases
por: Lan YJ, et al.
Publicado: (2021) -
Immunological strategy for detecting the pro-inflammatory cytokine TNF-alpha in salmonids
por: Rojas,Verónica, et al.
Publicado: (2012) -
IN VITRO ANALYSIS OF MIGRATION ACTIVITY OF ENCEPHALYTOGENIC T CEL
por: M. A. Nosov, et al.
Publicado: (2014) -
Systemic exposure to a single dose of ferucarbotran aggravates neuroinflammation in a murine model of experimental autoimmune encephalomyelitis
por: Hsiao YP, et al.
Publicado: (2019) -
Back to the Future? Immunoglobulin Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
por: Helen Brownlie, et al.
Publicado: (2021)